Bradley Moore, M.D.
NPI 1295963783 · Urology Physician · St. Joseph, MO
Enrolled with Medicare as Practitioner - Urology · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1295963783
- Entity type
- Individual
- Primary specialty
- Urology PhysicianAllopathic & Osteopathic Physicians
- Credential
- M.D.
- Sex
- Male
- Sole proprietor
- No
- License
- 2014009227 (MO)
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
16 yrs in NPPES registry
- Profile completeness25% of score
100% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
30,006 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Detection Test By Nucleic Acid for Organism, Amplified Probe Technique87798 | 4,064 | $34 |
| Chemical Analysis Using Spectrophotometry (light)84311 | 2,463 | $8 |
| Chronic Care Management Services, First 20 Minutes of Clinical Staff Time Directed By Health Care Professional, Per Calendar Month99490 | 1,285 | $58 |
| Bilirubin Level, Total82247 | 1,279 | $5 |
| Urine Hemoglobin Level83069 | 1,279 | $4 |
| Body Fluid Ph Level83986 | 1,274 | $4 |
| Urinalysis for Bacteria |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 38 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Finasteride | 1,046 | 284 |
| Tamsulosin Hcl | 856 | 230 |
| Nitrofurantoin Monohyd/M-Crystbrand: Nitrofurantoin Mono-Macro | 331 | 158 |
| Ciprofloxacin Hcl | 282 | 203 |
| Mirabegronbrand: Myrbetriq | 266 | 62 |
| Oxybutynin Chloridebrand: Oxybutynin Chloride Er | 165 | 43 |
| Methenamine Hippurate | 146 |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$895 across 48 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2009-06-23
- Last updated
- 2025-05-28
- Certified
- 2025-05-28
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.